Barely Significant
← all phrases

“did not reach statistical significance”

111,028 sentences · 111,028 papers · 130,054 search hits before verification

In the literature

Consistent with our previous results, iPSC-derived SNs with WT FUS showed a trend toward decreased tracing over time, which did not reach statistical significance ( Supplementary Figures S2C,D ). iPSC-derived SNs with P525L FUS-eGFP showed a 5-fold decrease in tracing ( p < 0.05, 2way ANOVA, Sidak post-test for multiple comparisons; Supplementary Figures S2C,D ), consistent with the age-dependent neurodegeneration observed in ALS.
Survivors with high CRC screening test knowledge were more likely to undergo screening, though this did not reach statistical significance (p=0.05) On multivariate analysis, physician’s recommendation, higher household income and survivors’ perceived need to undergo screening remained significantly correlated with actual CRC screening (OR 7.15 (95% CI 3.00 – 17.1), p<0.001; OR 3.32 (95% CI 1.33- 8.31), p=0.01; OR 7.10 (95% CI 3.08-16.4), p<0.001), whereas education level, family history and high CRC symptom knowledge were no longer significant ( Table 3 ).
In a 12-month, double-blind, randomised, placebo-controlled trial (VIDOMA trial), we previously found evidence for a greater improvement with omega-3 LCPUFA with or without vitamin D in social interaction in children with ASD compared with placebo but the difference did not reach statistical significance ( P < 0.05) for most comparisons.
001, iT1 <iT3; interaction: F(2,38.1) = 1.61, p=0.2), and the maximum avoidance time ( Figure 6D , right panel; genotype: F(1,27) = 4.04, p=0.054; trial: F(2,33.3) = 3.68, p=0.04, iT1 <iT3; interaction: F(2,33.3) = 0.39, p=0.7), although the differences between genotypes for the latter two measures did not reach statistical significance (i.e. p<0.05).
There were positive trends in the data regarding the impact on healthcare utilisation outcomes, but in general these did not reach statistical significance ( p < 0.05) within the 6-month follow-up period in intervention patients when compared with control patients.